Medindia LOGIN REGISTER
Medindia
Advertisement

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

Friday, May 24, 2019 General News
Advertisement
First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase 1b/2a clinical trial

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close